Netherlands· NL-4696110a8901
X-Praep, stroop 2 mg/ml
A senna glycosides product containing sennosiden a+b, registered in Netherlands by Viatris Healthcare B.V.. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Senna glycosides is registered in 8 of 19 countries.
Countries holding a registration under ATC A06AB06 (senna glycosides), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Senna glycosides · ATC A06AB06
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- SENNOSIDEN A+B
- Manufacturer
- Viatris Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- A06AB06
- ATC class
- Senna glycosides
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id07207
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Senna glycosides in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesChocolate LaxativeWal-Mart Stores Inc
- United KingdomCenlax 7.5mg tablets 12 Years PlusManx Healthcare Ltd
- SpainLAXANTE SALUD 7,5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULAPharmaceutical Innovation Services S.L.
- FrancePURSENNIDE 20 mg, comprimé enrobéHALEON FRANCE
- IrelandSenokot 7.5 mg/5 ml SyrupReckitt Benckiser Ireland Ltd
- NorwayPursennidHaleon Denmark ApS
- SwedenPursennid Ex-Lax 12 mg Dragerad tablettHaleon Denmark ApS
- FinlandExprepMundipharma Oy
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Cyprus · Senna Remedica
- Finland · Pursennid Ex Lax, Pursennid Ex-Lax
- France · Pursennide
- United Kingdom (Northern Ireland) · Sennosides 12 Years Plus Crescent Pharma, Sennosides 12 Years Plus Farmak Pharmaceuticals Uk
- Ireland · Senokot
- Italy · Pursennid
- Malta · Senna
- Norway · Pursennid
- Portugal · Pursennide
- Sweden · Pursennid Ex-Lax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d82ab056-9ac9-4d8b-8378-da70ebd160ca GET /v1/drugs/d82ab056-9ac9-4d8b-8378-da70ebd160ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stroop",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h07207_smpc.pdf",
"strength": null,
"atc_label": "Senna Glycosides",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg07207",
"excipients": [
"CACAOSMAAKSTOF",
"CHOCOLADESMAAKSTOF",
"ETHANOL 96 %",
"KALIUMSORBAAT (E 202)",
"METHYLPARAHYDROXYBENZOAAT (E 218)",
"NATRIUMHYDROXIDE (E 524)",
"PROPYLPARAHYDROXYBENZOAAT",
"SACCHAROSE",
"WATER, GEZUIVERD"
],
"substances": [
"SENNOSIDEN A+B"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h07207.pdf",
"authorised_at": "1976/06/09",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "07207",
"additional_monitoring": "N"
}See everything about senna glycosides.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.